Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05182931
Title A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Olivia Newton-John Cancer Research Institute

thyroid gland cancer


Dabrafenib + Trametinib


Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Royal North Shore Hospital Recruiting Sydney New South Wales Australia Details
Royal Brisbane and Women's Hospital Not yet recruiting Brisbane Queensland 4029 Australia Details
Eastern Health Not yet recruiting Box Hill Victoria 3128 Australia Details
Monash Health Not yet recruiting Clayton Victoria 3168 Australia Details
Austin Health Recruiting Heidelberg Victoria 3084 Australia Details
Alfred Hospital Not yet recruiting Prahran Victoria Australia Details
Sir Charles Gairdner Hospital Not yet recruiting Perth Western Australia Australia Details
Peter MacCallum Cancer Centre Not yet recruiting Melbourne Australia Details
*Shaded cells indicate that there was no data available from for the field